WHO Proposes Regulatory Flexibilities For Testing MAbs Against Infectious Diseases

A draft guideline from the World Health Organization intends to clarify regulatory expectations for the assessment of mAbs used for preventing and treating infectious diseases in health emergencies and to help with international harmonization efforts in this field.